Pharmacy Daily | Partnership is the future

Medicines Australia (MA) has called for renewed focus on the medicines industry, and has said it is keen to work with government and other stakeholders to find the best strategies to do this. Ceo Dr Brendan Shaw said at the opening of the fifth Pharmaceutical Sciences World Congress in Melbourne that the country had “a rich heritage” of medicines derived from the natural environment and from medical research. “The community is interested, the government is interested, the research community is interested and the industry is interested in taking the step to the next level of commercial partnership between science, research and commercialisation. “We want an environment that fosters more investment and more partnerships between the public researchers and private industry. Shaw told PD that MA was not asking for direct funding but there were various initiatives that had been successfully used in Australia and overseas to generate “significant” investment by the medicines industry. “The key thing is getting a whole of government approach that takes into account the importance of maintaining a stable and predictable business operating environment, ensuring a strong IP system and an efficient and cost effective environment for clinical trials and having globally competitive incentives which enhance Australia’s attractiveness as a destination for global investment in high-tech pharmaceutical manufacturing and R&D.” CLICK HERE for the full speech.

---

The above article was sent to subscribers in Pharmacy Daily's issue from 16 Apr 14
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Apr 14